S&P 500   4,584.15 (+0.77%)
DOW   36,124.07 (+0.19%)
QQQ   390.77 (+1.49%)
AAPL   194.91 (+1.35%)
MSFT   370.89 (+0.57%)
META   327.05 (+3.02%)
GOOGL   138.29 (+6.36%)
AMZN   147.68 (+2.19%)
TSLA   240.87 (+0.63%)
NVDA   463.81 (+1.93%)
NIO   7.44 (-4.00%)
BABA   72.22 (+1.02%)
AMD   126.59 (+8.36%)
T   17.08 (+0.83%)
F   10.81 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.73 (+4.93%)
GE   118.36 (-1.21%)
DIS   92.89 (+1.52%)
AMC   6.85 (+0.88%)
PFE   28.77 (-0.07%)
PYPL   58.31 (-2.05%)
XOM   98.49 (-0.63%)
S&P 500   4,584.15 (+0.77%)
DOW   36,124.07 (+0.19%)
QQQ   390.77 (+1.49%)
AAPL   194.91 (+1.35%)
MSFT   370.89 (+0.57%)
META   327.05 (+3.02%)
GOOGL   138.29 (+6.36%)
AMZN   147.68 (+2.19%)
TSLA   240.87 (+0.63%)
NVDA   463.81 (+1.93%)
NIO   7.44 (-4.00%)
BABA   72.22 (+1.02%)
AMD   126.59 (+8.36%)
T   17.08 (+0.83%)
F   10.81 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.73 (+4.93%)
GE   118.36 (-1.21%)
DIS   92.89 (+1.52%)
AMC   6.85 (+0.88%)
PFE   28.77 (-0.07%)
PYPL   58.31 (-2.05%)
XOM   98.49 (-0.63%)
S&P 500   4,584.15 (+0.77%)
DOW   36,124.07 (+0.19%)
QQQ   390.77 (+1.49%)
AAPL   194.91 (+1.35%)
MSFT   370.89 (+0.57%)
META   327.05 (+3.02%)
GOOGL   138.29 (+6.36%)
AMZN   147.68 (+2.19%)
TSLA   240.87 (+0.63%)
NVDA   463.81 (+1.93%)
NIO   7.44 (-4.00%)
BABA   72.22 (+1.02%)
AMD   126.59 (+8.36%)
T   17.08 (+0.83%)
F   10.81 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.73 (+4.93%)
GE   118.36 (-1.21%)
DIS   92.89 (+1.52%)
AMC   6.85 (+0.88%)
PFE   28.77 (-0.07%)
PYPL   58.31 (-2.05%)
XOM   98.49 (-0.63%)
S&P 500   4,584.15 (+0.77%)
DOW   36,124.07 (+0.19%)
QQQ   390.77 (+1.49%)
AAPL   194.91 (+1.35%)
MSFT   370.89 (+0.57%)
META   327.05 (+3.02%)
GOOGL   138.29 (+6.36%)
AMZN   147.68 (+2.19%)
TSLA   240.87 (+0.63%)
NVDA   463.81 (+1.93%)
NIO   7.44 (-4.00%)
BABA   72.22 (+1.02%)
AMD   126.59 (+8.36%)
T   17.08 (+0.83%)
F   10.81 (+1.12%)
MU   73.65 (+0.71%)
CGC   0.73 (+4.93%)
GE   118.36 (-1.21%)
DIS   92.89 (+1.52%)
AMC   6.85 (+0.88%)
PFE   28.77 (-0.07%)
PYPL   58.31 (-2.05%)
XOM   98.49 (-0.63%)

Shockwave Medical Stock Price, News & Analysis (NASDAQ:SWAV)

$172.52
-0.01 (-0.01%)
(As of 12:40 PM ET)
Compare
Today's Range
$169.45
$172.99
50-Day Range
$160.99
$215.69
52-Week Range
$157.00
$315.95
Volume
133,688 shs
Average Volume
574,057 shs
Market Capitalization
$6.37 billion
P/E Ratio
26.87
Dividend Yield
N/A
Price Target
$263.00

Shockwave Medical MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
52.5% Upside
$263.00 Price Target
Short Interest
Healthy
4.36% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.55
Upright™ Environmental Score
News Sentiment
0.35mentions of Shockwave Medical in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$9.07 M Sold Last Quarter
Proj. Earnings Growth
24.86%
From $3.62 to $4.52 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.24 out of 5 stars

Medical Sector

9th out of 958 stocks

Surgical & Medical Instruments Industry

4th out of 77 stocks


SWAV stock logo

About Shockwave Medical Stock (NASDAQ:SWAV)

ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

SWAV Stock Price History

SWAV Stock News Headlines

An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
ShockWave Medical Inc SWAV
Shockwave Medical: Buying The Dip
Shockwave Medical (SWAV) Q3 2023 Earnings Call Transcript
See More Headlines
Receive SWAV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/06/2023
Today
12/07/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/15/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SWAV
Fax
N/A
Employees
1,001
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$263.00
High Stock Price Target
$315.00
Low Stock Price Target
$218.00
Potential Upside/Downside
+52.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$216 million
Pretax Margin
24.35%

Debt

Sales & Book Value

Annual Sales
$671.28 million
Cash Flow
$5.80 per share
Book Value
$14.15 per share

Miscellaneous

Free Float
35,643,000
Market Cap
$6.37 billion
Optionable
Not Optionable
Beta
0.87
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives















SWAV Stock Analysis - Frequently Asked Questions

Should I buy or sell Shockwave Medical stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SWAV shares.
View SWAV analyst ratings
or view top-rated stocks.

What is Shockwave Medical's stock price target for 2024?

10 brokerages have issued 12-month price targets for Shockwave Medical's stock. Their SWAV share price targets range from $218.00 to $315.00. On average, they anticipate the company's share price to reach $263.00 in the next year. This suggests a possible upside of 52.5% from the stock's current price.
View analysts price targets for SWAV
or view top-rated stocks among Wall Street analysts.

How have SWAV shares performed in 2023?

Shockwave Medical's stock was trading at $205.61 at the beginning of the year. Since then, SWAV shares have decreased by 16.1% and is now trading at $172.49.
View the best growth stocks for 2023 here
.

When is Shockwave Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024.
View our SWAV earnings forecast
.

How were Shockwave Medical's earnings last quarter?

Shockwave Medical, Inc. (NASDAQ:SWAV) posted its quarterly earnings data on Monday, November, 6th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.11. The firm earned $186.02 million during the quarter, compared to analysts' expectations of $184.71 million. Shockwave Medical had a net margin of 36.33% and a trailing twelve-month return on equity of 42.41%. The business's revenue for the quarter was up 41.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.92 EPS.

What is Doug Godshall's approval rating as Shockwave Medical's CEO?

8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did Shockwave Medical IPO?

(SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who are Shockwave Medical's major shareholders?

Shockwave Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include FMR LLC (6.85%), Wellington Management Group LLP (4.89%), Artisan Partners Limited Partnership (3.80%), Invesco Ltd. (1.92%), Allspring Global Investments Holdings LLC (1.76%) and Morgan Stanley (1.17%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy and Trinh Phung.
View institutional ownership trends
.

How do I buy shares of Shockwave Medical?

Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:SWAV) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -